fatimi20

[joeypetter]

Sperm Bank Market Growth, Statistics, Size, Latest Industry Innovations, Emerging Trends, Future Demands and Forecast 2030| By R&I

The report is titled as ‘Sperm Bank Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the sperm bank market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Sperm bank market is expected to grow with significant rate in the near future.

The global sperm bank market in 2020 is estimated for more than US$ 4.6 Bn and expected to reach a value of US$ 5.9 Bn by 2028 with a significant CAGR of 3.4%.

Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/1266

MMC Overview

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the sperm bank market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market. Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Wish to Know More About the Study? Click here to get a Report Description: https://reportsandinsights.com/report/global-sperm-bank-market

Sperm Bank Market Segmentation

The global sperm bank market is segmented on the basis of donor type, service type, end use, and region.

On the Basis of Donor Type

    Known Donor

    Anonymous Donor

On Basis of Service Type

    Sperm Storage

    Semen Analysis

    Genetic Consultation

On Basis of End Use

    Donor Insemination

    In vitro Fertilization

By Region

    North America

    Latin America

    Europe

    Asia Pacific

    Middle East

    Africa

Sperm Bank Market Key Players

Some of the key participating players in the global sperm bank market are

    Cryo-Save AG

    Androcryos

    New England Cryogenic Center

    Indian Spermtech

    European Sperm Bank

    Seattle Sperm Bank

    Fairfax Crobank Inc.

    London Sperm Bank

    Xytex Corporation

To view Top Players, Segmentation and other Statistics of Sperm Bank Industry, Get Sample Report @: https://reportsandinsights.com/sample-request/1266

About Reports and Insights:

Reports and Insights is one of the leading market research companies which offers syndicate and consulting research around the globe. At Reports and Insights, we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us:

Neil Jonathan

1820 Avenue M, Brooklyn

NY 11230, United States

+1-(718) 312-8686

Find Us on LinkedIn: www.linkedin.com/company/report-and-insights/

View Latest Market Updates At: https://marketsresearchanalytics.com

[researchupdate]

High Incidence of Infertility and Government Initiatives to Boost Adoption of In-Vitro Fertilization to Augment Growth of Infertility Treatment Devices and Equipment (PDF Guideline)

The growth of the infertility treatment devices and equipmentmarket is mainly attributed to the increasing incidence of infertility in both sexes and rising number of fertility clinics and infertility services with government support. However, the high procedural cost of reproductive techniques hinders the market growth.

Fertility clinics are among medical clinics that support couples to gain fertility. Sometimes, individuals who want to conceive pregnancy but for medical reasons have been unable to achieve this goal through the natural course. There are several fertility clinics and services offered in the counties of NA and Europe to prevent infertility. Assisted reproductive technology (ART) now produces more than 50,000 babies per year in the US through 330,000 in vitro fertilization (IVF) procedures. Demand is growing from the ranks of more than seven million infertile women, many of which delayed childbearing due to careers. In the US, there are about 450 fertility clinics, more than 100 sperm banks, an unknown number of egg donors, and 1,700 reproductive endocrinologists competing for the business. IntegraMed and Prelude Fertility exist in the two large chains, as most programs are run by small M.D. practices or are part of a hospital or University. Various government initiatives and changes in the legal system drive the demand for assisted reproduction procedures in clinics. In the US, around 14 states cover infertility treatment under medical insurance. In Canada, the government is initiating measures to control the declining population, wherein it has sponsored various cycles of artificial insemination and IVF.

Click Here For More: https://www.businessmarketinsights.com/sample/TIPRE00016085?utm_source=Social&utm_medium=10457

[newsinsights]

Cryopreservation for In-vitro Fertilization (IVF) Market is set to reflect an impressive 10.2% CAGR through 2030

A recent market study published by Future Market Insights (FMI) on the cryopreservation for in-vitro fertilization (IVF) market includes global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the cryopreservation for in-vitro fertilization (IVF) market, growth prospects are obtained with maximum precision.

Cryopreservation for In-vitro Fertilization (IVF) Market: Segmentation

The global cryopreservation for in-vitro fertilization (IVF) market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

Cryopreservation Media

Cryopreservation Storage Devices

Dewars

Cryogenic Liquid Cylinders

Cryogenic Storage Tanks

Storage Container

Consumables & Accessories

Cryo-Shipping

Vapor Tanks

Storage Alarm Systems

LN 2 Auto Fill Systems

LN2 Sterilization System

Cryo Control/Inventory Management Systems

Cryocanes

Visotubes

Cannisters

Vitrification Carriers

Sperm Straws

Saw Freeze Straws

Cryovials

Dry Shipper Container

Clinical Pack Over Wrap

Cryogenic Labels

Application

Oocycte Cryopreservation

Sperm Cryopreservation

Embryo Cryopreservation

End User

Biobanks

IVF & Fertility Clinics

Research & Academic Institutes

Cryo-shipping/couriers

Cryo Monitoring /Inventory Management

Regional Outlook

North America (US, Canada)

Latin America (Brazil, Mexico, Argentina, Rest of LATAM)

Europe (Germany, UK, Russia, France, Italy, Spain, BENELUX, Rest of Europe)

South Asia (India, Thailand, Indonesia, Malaysia, Rest of South Asia)

East Asia (China, Japan, and South Korea)

Oceania (Australia, New Zealand)

Middle East & Africa (GCC Countries, Turkey, South Africa, and Rest of MEA)

Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12785

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint.

Report Chapters

Chapter 01 – Executive Summary

The report initiates with the executive summary of the cryopreservation for in-vitro fertilization (IVF) market, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the cryopreservation for in-vitro fertilization (IVF) market.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the cryopreservation for in-vitro fertilization (IVF) market in this chapter, which will help them understand the basic information about the market.  

Chapter 03 – Key Market Trends

This chapter highlights the key trends impacting the growth of the cryopreservation for in-vitro fertilization (IVF) market over the forecast period. This chapter helps reader to understand the trends of cryopreservation for in-vitro fertilization (IVF) market.

Chapter 04 ­– Key Success Factors

This section includes key success factors such as product adoption analysis, application road map, key promotional strategies, regulations, and many more. This section helps readers understand the key factors associated with the cryopreservation for in-vitro fertilization (IVF) market.

Chapter 05 – Market Background

This chapter explains the key macroeconomic factors, drivers, restraints, and opportunity analysis that are expected to influence growth of the cryopreservation for in-vitro fertilization (IVF) market over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.

Any Queries, Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-12785

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies

Detailed insights of market segments and sub-segments for historical as well as forecast period

A competitive analysis of prominent players and emerging players in the In Vitro Fertilization Banking Services Market

Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Visit More Healthcare Reports:

Gene Editing Tools Market: Gene Editing Tools Market: Profitable Technology Transfer for CRISPR to Boost Revenues: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

Venous Thromboembolism Treatment Market:  Venous Thromboembolism Treatment Market: US Remains the Front Runner Driven by Favorable Reimbursement Scenario: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

Bone Growth Stimulators Market: Bone Growth Stimulators Market: Fractures & Spinal Fusion Surgeries Continue to Generate Sizeable Demand: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

[rishabh3210blog]

Assisted Reproductive Technology Market Size, Growth Analysis Report, Forecast to 2021-2027

The global assisted reproductive technology market is anticipated to grow at a considerable CAGR of 8.7% during the forecast period. The rising investment in research lab expansion is a key factor promoting the growth of the assisted reproductive technology market. For instance, in March 2021, Gulf Capital, an alternative investment firm has announced to invest $30 million in its two-year growth plans for ART Fertility Clinics, a fast-growing provider of fertility treatment services in the Gulf Cooperation Council (GCC) states.

(Get 15% Discount on Buying this Report)

Get Report Sample Copy @ https://www.omrglobal.com/request-sample/assisted-reproductive-technology-market

Under its two-year growth plan, ART fertility announced to launch 18 clinics in the next 12 months across India. Rising investment from private entities in the expansion of semen and embryology labs to ensure a non-toxic, pathogen-free, and stable environment for gamete handling is anticipated to offer lucrative opportunities to the growth of the assisted reproductive technology industry.

A Full Report of Global Assisted Reproductive Technology Market is Available at: https://www.omrglobal.com/industry-reports/assisted-reproductive-technology-market

In January 2021, the Fertility Partners, Canada's renowned platform of fertility practices has acquired the Toronto Institute For Reproductive Medicine and ReproMed. With the west-end Greater Toronto Area (GTA) fertility treatment providers joining its network of partner clinics, TFP has expanded its presence in the GTA to 5 locations and expands its high-quality Canadian donor sperm services. Ongoing market developments are anticipated to expand the growth of the assisted reproductive technology market.

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

How has COVID-19 impacted the market?

o          Deviation from the pre-COVID-19 forecast

o          Most affected region and segment

Who is the leader in the market?

How players are addressing challenges to sustain growth?

Where is the investment opportunity?

Global Assisted Reproductive Technology Market Report Segment

By Technology

In Vitro Fertilization

Others

By Procedure

Frozen Donor

Frozen Non-Donor

Fresh Donor

Fresh Non-Donor

Embryo Banking

Global Assisted Reproductive Technology Market Report Segment by Region

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Rest of the World

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/assisted-reproductive-technology-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 780-304-0404

[joeypetter]

Sperm Bank Market Growth, Statistics, Size, Latest Industry Innovations, Emerging Trends, Future Demands and Forecast 2030| By R&I

The report is titled as ‘Sperm Bank Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the sperm bank market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Sperm bank market is expected to grow with significant rate in the near future.

The global sperm bank market in 2020 is estimated for more than US$ 4.6 Bn and expected to reach a value of US$ 5.9 Bn by 2028 with a significant CAGR of 3.4%.

Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/1266

MMC Overview

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the sperm bank market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market. Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Wish to Know More About the Study? Click here to get a Report Description: https://reportsandinsights.com/report/global-sperm-bank-market

Sperm Bank Market Segmentation

The global sperm bank market is segmented on the basis of donor type, service type, end use, and region.

On the Basis of Donor Type

    Known Donor

    Anonymous Donor

On Basis of Service Type

    Sperm Storage

    Semen Analysis

    Genetic Consultation

On Basis of End Use

    Donor Insemination

    In vitro Fertilization

By Region

    North America

    Latin America

    Europe

    Asia Pacific

    Middle East

    Africa

Sperm Bank Market Key Players

Some of the key participating players in the global sperm bank market are

    Cryo-Save AG

    Androcryos

    New England Cryogenic Center

    Indian Spermtech

    European Sperm Bank

    Seattle Sperm Bank

    Fairfax Crobank Inc.

    London Sperm Bank

    Xytex Corporation

To view Top Players, Segmentation and other Statistics of Sperm Bank Industry, Get Sample Report @: https://reportsandinsights.com/sample-request/1266

About Reports and Insights:

Reports and Insights is one of the leading market research companies which offers syndicate and consulting research around the globe. At Reports and Insights, we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us:

Neil Jonathan

1820 Avenue M, Brooklyn

NY 11230, United States

+1-(718) 312-8686

Find Us on LinkedIn: www.linkedin.com/company/report-and-insights/

View Latest Market Updates At: https://marketsresearchanalytics.com

[decisionforsight]

Global Biopreservation Market

Global Biopreservation Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030

The global biopreservation market accounted 3.2 billion USD in 2020 and is expected to reach 13.2 billion USD by 2030 with a CAGR of 15.1% approximately during the forecast period.Biopreservation is a process that involves the preservation and storage of bio-specimens like purified DNA, saliva, and plasma. It enables the stability, quality, and purity of bio-specimens. The process of biopreservation is carried out with the help of lactic acid bacteria as they are inhibitory to microbes responsible for decomposition. It has developed as an effective preservation method for long-term storage. Because of this, biopreservation has become a vital tool for the success of numerous clinical and commercial applications of the developing cell-based technologies. Currently, it is been extensively used for retaining the integrity and functionality of clinical trials material, stem cells, embryos, sperms, and eggs in several research and healthcare institutions.   

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020172

Market Dynamics and Factors:

Growing prevalence of chronic disorders, rising healthcare expenditure, and increasing government spending on R&D are the major factors driving the global biopreservation market. For instance, according to the National Diabetes Statistics Report 2017, around 30 million people which comprises of almost 9.4% of the U.S. population had diabetes in 2015. Scarcity of organ donors for transplantation purposes is going to augment the demand for regenerative medicines which will in turn escalate the biopreservation market growth in the coming future. In addition to that, other major driving factors include growing research in drug discovery, increase in the number of bio-banks to store biological products used in various kinds of medical research, and government initiatives to promote bio-banking for disease treatment. For instance, government initiatives such as International Society of Biological and Environmental Repositories to enrich bio-banking and preservation standards and practices is creating huge opportunities for the biopreservation market to grow in the coming future. However, certain factors like high cost of biopreservation devices, stringent norms for the production of biopreservation products, and the emergence of room temperature storage techniques are hindering the growth of the biopreservation market. Furthermore, increasing R&D by key players in order to enhance their capabilities and provide efficient products and services is expected to further expand growth prospects for the market.

Market Segmentation:

Global Biopreservation Market – By Product Type

Equipments

Freezers

Refrigerators

Consumables

Liquid Nitrogen

Media

Nutrient Media

Sera

Growth Factors & Supplements

Laboratory Information Management System

Global Biopreservation Market – By Application

Regenerative Medicine

Cell Therapy

Gene Therapy

Others

Biobanking

Human Eggs

Human Sperms

Veterinary Ivf

Drug Discovery

Global Biopreservation Market – By Cell Providers Volume

Cd 34+

Cd19+

MSC

IPSC

HESC

Tumor Cells

Others

Global Biopreservation Market – By End-Users

Hospitals

Bio-Banks

Gene Banks

Others

Global Biopreservation Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020172 

Geographic Analysis:

North America is expected to dominate the global biopreservation market in terms of market share during the forecast period. Increasing prevalence of chronic disorders like diabetes, renal failure leading to organ damage has augmented the scope of organ transplantation in the region. Thus, positively impacting the biopreservation market in the region. For instance, according to the U.S. Department of Health & Human Services, almost 114,000 people were on the national transplant waiting list as of August 2017. This in turn has increased the adoption rate of regenerative medicine in disease treatment and contributed to the growth of the biopreservation market in the region. Other major factors include robust healthcare infrastructure, and government investments in R&D attributing to the market dominance of the region. Europe is expected to be the second most dominating market for biopreservation products during the forecast period. Increasing government support in networking of bio-banks such as UK Bio-bank and international collaborations for expanding the scope of bio-banking are the major factors attributing to the market growth in the region. The Asia Pacific market is anticipated to witness the fastest growth in the biopreservation market during the forecast period. Consistent rise in number of patients suffering from chronic diseases, and increasing government investments in R&D is widening the scope for adoption of bio-storage, thereby boosting the market growth across the APAC region.

Competitive Scenario:

The key players operating in the global biopreservation market are –

BioLife Solutions, BioCision, Biomatrica, Chart MVE Biomedical, Thermo Fisher Scientific, Panasonic Biomedical, Taylor-Wharton Cryogenics, Atlanta Biologics, Qiagen, Princeton Cryotech Inc.    

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020172 

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Biopreservation industry, although key threats, opportunities and disruptive technologies that could shape the Global Biopreservation Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Biopreservation Market most.

The data analysis present in the Global Biopreservation Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Biopreservation Market business.

The 2021 Annual Global Biopreservation Market offers:

100+ charts exploring and analysing the Global Biopreservation Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Biopreservation Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020172 

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

[karishmamulani]

Sperm Banks Market Growth Factors, Latest Trend And Regional Analysis Of Leading Players By 2027

The global sperm bank market expected to reach USD 6.07 billion by 2028 according to a new study by Polaris Market Research. The report “Sperm Bank Market Share, Size, Trends, Industry Analysis Report, By Service Type (Sperm Storage, Semen Analysis, Genetic Consultation); By Donor Type (Known Donor, Anonymous Donor); By End-Use (Donor Insemination, In-vitro Fertilization), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global sperm bank industry is driven by few notable factors such as rising cases of infertility among both men and women, innovations in assistive reproductive techniques, and an increasing number of infertility care centers across the globe. Moreover, the growing awareness among consumers in the middle-income countries also boosting the industry growth.

The global sperm bank industry is fragmented based on service type, donor, end-use, and region. In terms of service type, the market is segmented sperm storage, semen analysis, and genetic consultation. Based on the donor type, the market is classified as known and anonymous donors. The end-use segment is further divided into donor insemination and in-vitro fertilization.

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/sperm-bank-market/request-for-sample

Segment Highlights

The semen analysis segment accounted for the largest revenue share in 2020 owing to its use in examination of sperm count and associated complications. The market segment accounted for over 45% of the global market in 2020.

Known donor market segment accounted for over 50% of the revenue share in 2020 and is expected to dominate across the forecast period owing to the several right to know your biological parent mandates in developed economies.

Based on end-use, the in-vitro fertilization market segment is projected to constitute over 95% of the market share by 2028. This can be attributed to the rising cases of miscarriages and high success rate of in-vitro fertilization.

North America sperm bank industry is expected to dominate the global market. Rising awareness among individuals about the ill-effects of infertility and the presence of robust infrastructure for sperm banking services are the factors responsible for market growth.

Fairfax Cryobank Inc., Xytex Corporation, Andocryos, Cryo-Save AG, New England Cryogenic Center, Seattle Sperm Bank, and Indian Spermtech are few of the major players operating in the market space.

List of Key Players

Fairfax Cryobank Inc.

Xytex Corporation

Andocryos

Cryo-Save AG

Indian Spermtech

New England Cryogenic Center

Seattle Sperm Bank

London Sperm Bank

Others

Have Any Query Or Specific Requirement? Feel Free To Ask Our Industry Experts At : https://www.polarismarketresearch.com/industry-analysis/sperm-bank-market/speak-to-analyst

Polaris Market Research has segmented the Sperm Bank Market report on the basis of service type, donor type, end-use, and region

Sperm Bank, Service Type Outlook (Revenue – USD Million, 2016 – 2028)

Sperm storage

Semen analysis

Genetic consultation

Sperm Bank, Donor Outlook (Revenue – USD Million, 2016 – 2028)

Known donor

Anonymous donor

Sperm Bank, End-Use Outlook (Revenue – USD Million, 2016 – 2028)

Donor insemination

In vitro fertilization

Sperm Bank, Regional Outlook (Revenue – USD Million, 2016 – 2028)

North America

Europe

Asia Pacific

Central & South America

Middle East & Africa

U.S.

Canada

France

Germany

UK

Italy

Spain

Netherlands

Austria

China

India

Japan

Malaysia

South Korea

Indonesia

Mexico

Brazil

Argentina

UAE

Saudi Arabia

Israel

South Africa

Read More : https://www.medgadget.com/2021/01/sperm-bank-market-size-is-projected-to-reach-6-07-billion-by-2028-cagr-3-5-polaris-market-research.html

[esglatestmarketnews]

Biopreservation Market Scenario, Outlook and Forecast till 2022

January 20, 2021:  The global Biopreservation Market size is likely to reach USD 8.93 billion by 2022 which is projected to grow at a CAGR of 17.3% during the forecast period. Rapid growth can be attributed to the rise in healthcare expenditure which is expected to boost the market in the forecast period. Moreover, increasing R&D activities by various companies as well as research organizations funded by government initiatives in the form of grant, contacts and various other funding mechanisms have led to development of novel and innovative bio-preservation services, leading to augment the revenue growth. Growing use of bio-preservation are also supported by the rising participation of government or non-government bodies for the development of this field. For example, due to the support of the institutional and government repositories, the storage of bio-specimen has evolved to next level of advanced information from basics of patient’s phenotype, extending to genetics as well as “omics” such as proteomic information.

Product Insights The key segments included laboratory information management systems (LIMS), media and equipment. In 2014, the equipment segment dominated the market which includes liquid nitrogen, consumables, refrigerators and freezers, having a revenue share of more than 80%. The larger share can be attributed to the high demands pertaining to bio-banks and the extensive use and importance of the aforementioned products in bio-preservation. Media segment which includes home brewed and pre-formulated media is projected to witness a healthy growth as a consequence of the increased demands of tissues, cells and other materials in bio banking and advanced products in regenerative medicines. Furthermore, the high share and preference of home brewed media in terms of bio-storage can be attributed to its cost-efficiency and effectiveness in comparison to pre-formulated media. Request a Free Sample Copy of this Report @ https://www.millioninsights.com/industry-reports/biopreservation-market/request-sample Application Insights The major application analyzed in the study comprised of drug discovery, bio-banking and regenerative medicines. Moreover, the further segmentation of bio-banking includes veterinary IVF, human sperm and human eggs. Bio-banking segment held the largest share of 72.5% in 2014. Rising awareness related to preservation of stem cells, use of assisted technology for reproduction in animals and increasing number of sperm and egg banks are anticipated to drive the growth. Additionally, the expected rise in the revenue share of the segment can be attributed to advent of new techniques used for preservation of cells for a longer span of time. Regenerative medicine is considered to be the fastest growing segment owing to the high demand pertaining to efficient and specialized techniques for bio-storage. Moreover, huge amount of investments by non-government or government organizations in the field of regenerative cell therapy research is projected to boost the growth of the overall market.

Cell providers Insights The segment of cell providers can be analyzed on basis of tumor cells, hESC, iPSC, MSC, CD19+, and CD34+. The largest market share was held by tumor cells in terms of volume in 2014 as a consequence of their wide array of application in treatment, diagnosis and R&D of the most prevalent forms of cancer. However, the fastest growing segment is predicted to be the iPSC segment throughout the forecast period because of their promising application in regenerative medicines owing to their high propagating capacity. Regional Insights Key market in 2014 was the North American having a revenue share of more than 45% owing to the innovative drug developments and therapies pertaining to the biomedical research. Also, continuous rise in the population base with chronic and acute disorders requiring treatment and diagnosis in the region is further drive the revenue generation. Asia Pacific region is expected to show a considerable growth rate over the forecast period owing to the rise in population base suffering from life threatening disorders. Moreover, increasing investments by government in R&D is leading to an urgent need for bio-storage, therefore providing a boost to the regional market. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/biopreservation-market Market Share Insights The key players holding a significant share of the biopreservation market include Qiagen, Thermo Fisher Scientific Inc, Panasonic Biomedical, Atlanta Biologicals, LabVantage Solutions Inc., Chart MVE Biomedical, BioLife Solutions Inc., Biomatrica and BioCision. The strategic initiatives by the company including acquisitions, mergers and new product launches are done to maintain and gain a competitive edge. For instance, ATCC and BioCision in May 2013 entered in an agreement to distribute and develop line of CoolProducts having a wide array of applications in wielding procedures and biomaterials storage.

Market Segment:

Biopreservation Product Outlook (Revenue, USD Billion, 2012 - 2022)    • Equipment        • Freezers        • Refrigerators        • Consumables            • Vials            • Straws            • Microtiter Plates            • Bags        • Liquid Nitrogen    • Media        • Pre-formulated        • Home-brew    • Laboratory Information Management System (LIMS) Biopreservation Application Outlook (Revenue, USD Billion, 2012 - 2022)    • Regenerative Medicine        • Cell therapy        • Gene therapy        • Others    • Bio-banking        • Human eggs        • Human sperms        • Veterinary IVF    • Drug Discovery Biopreservation Cell Providers Outlook (Volume, Number of Units, 2012 - 2022)    • CD34+    • CD19+    • MSC    • iPSC    • hESC    • Tumor Cells    • Others Biopreservation Market Regional Outlook (Revenue, USD Billion, 2012 - 2022)    • North America        • U.S.        • Canada    • Europe        • UK        • Germany    • Asia Pacific        • Japan        • China    • Latin America        • Brazil        • Mexico    • MEA        • South Africa Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com

[marketreport]

In Vitro Fertilization Banking Services Market Pegged for Robust Expansion During 2020-2030

A recent market study published by Future Market Insights (FMI) on the in vitro fertilization banking services market offers global industry analysis for 2015-2019 & opportunity assessment for 2020-2030. The report consists of a comprehensive assessment of the most important market dynamics.

On conducting thorough research on the historical as well as current growth parameters of the in vitro fertilization banking services market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the growth of the in vitro fertilization banking services market during the forecast period.

It can help services providers to modify their services strategies to envisage maximum growth in the in vitro fertilization banking services market in the coming years. The report provides detailed information about the current and future growth prospects of the in vitro fertilization banking services market in the most comprehensive way for better understanding of readers.

To Get the Sample Copy of Report visit @https://www.futuremarketinsights.com/reports/sample/rep-gb-12789

Key Segments of In vitro fertilization banking services market

FMI’s study on the in vitro fertilization banking services market offers information divided into two important segments— services type and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Service Type

 Fresh Donor Egg Cycle

 Frozen Donor Egg Cycle

 Andrology Services

 Sperm Storage

Region

North America

Latin America

Western Europe

Eastern Europe

Asia Pacific Excluding Japan

Middle East and Africa

Japan

Chapter 01 – Executive Summary

The report commences with the executive summary of the in vitro fertilization banking services market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the in vitro fertilization banking services market as well as the key trends impacting the market.

Chapter 02 – Market Overview

Readers can find detailed taxonomy and product definition of the in vitro fertilization banking services market, in this chapter. This section also provides the key inclusions and exclusions of the market which help readers understand basics of in vitro fertilization banking services market.

Ask an Analyst @https://www.futuremarketinsights.com/ask-question/rep-gb-12789

Chapter 03 – Key Market Trends

This section highlights the key trends impacting the in vitro fertilization banking services market, which will help readers understand the current trends and their impact on market growth.

Chapter 04 – Key Success Factors

This section highlights the key context of the market such as IVF adoption analysis, key strategies followed by leading market players, regulatory scenario, reimbursement scenario, IVF process steps, which will help readers to gain extensive knowledge about the in vitro fertilization banking services market.

Chapter 05 – Market Background

This chapter explains the key macroeconomic factors that are expected to influence the growth of the in vitro fertilization banking services market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the in vitro fertilization banking services market, which include the drivers, restraints, and opportunity analysis. This chapter is expected to enable readers to understand the factors that are propelling the growth of the in vitro fertilization banking services market, as well as those that are likely to hamper the growth of the in vitro fertilization banking services market. The opportunity analysis for the in vitro fertilization banking services market will help readers to understand the market opportunities, based on which they can plan their strategies.

Chapter 06 – COVID 19 Impact Analysis

This section highlights the current COVID19 statistics and probable future impact. In this chapter the readers can also find information about the short term, midterm and long term impact on the in vitro fertilization banking services market across the key regions of the globe.

Chapter 07 – Global In Vitro Fertilization Banking Services Market Pricing Analysis

This section covers the pricing analysis of the market on the basis of region and other attributes in this chapter. It will help the reader find comparative analysis of product pricing across different regions of the globe.

Chapter 08 – Global In Vitro Fertilization Banking Services Market Value (US$) Analysis 2015-2019 and Forecast 2020-2030

This section explains the global market value analysis and forecast for the in vitro fertilization banking services market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).

Chapter 09 – Global In vitro Fertilization Banking Services Market Analysis (2015-2019) & Opportunity Assessment (2020-2030), By Service Type

Based on services type, the in vitro fertilization banking services market is segmented into egg banking and sperm banking. The egg banking segment is further segmented in to fresh donor egg cycle and frozen donor egg cycle. The sperm banking segment is further divided into andrology servicess and sperm storage. In this chapter, readers can find information about a detailed analysis of the market by different services type and their growth over the forecast period.

Chapter 10 – Global In Vitro Fertilization Banking Services Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, By Region

This chapter explains how the in vitro fertilization banking services market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).

Buy this report @https://www.futuremarketinsights.com/checkout/12789

Chapter 11 – North America In Vitro Fertilization Banking Services Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter includes a detailed analysis of the growth of the North America in vitro fertilization banking services market along with the country-wise assessment including the U.S. and Canada. Readers can also find attractiveness index analysis, key takeaways of this region, and market growth based on services type, and country in the North American region.

so on..

[kunalcmi]

HUMAN REPRODUCTIVE TECHNOLOGIES MARKET ANALYSIS(2020-2027)

Human reproductive technologies include, Assisted Reproductive Technology (ART), prognostics, contraception, and same-sex procreation. ART aids in the treatment of low fertility or infertility using artificial insemination, artificial reproduction, cloning, cytoplasmic transfer, fertility medication, hormone treatment, and others.

 The global human reproductive technologies market is estimated to account for US$ 28,426.7 Mn in 2019 in terms of value and US$ 34,228.3 Mn by the end of 2027.

 Global Human Reproductive Technologies Market: Drivers

Increasing prevalence of maternal mortality is expected to propel growth of the global human reproductive technologies market over the forecast period. For instance, according to Maternal Mortality: 1990 to 2015 Estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division, Sub-Saharan Africa recorded the highest ratio or maternal mortality, at 555 per 100, 000 live births, from 1990 to 2015. Moreover, the United Nations is focused on achieving the Sustainable Development Goals 2015 - 2030 global maternal mortality ratio target of less than 70 per 100 000 live births.

Moreover, decreasing birth rate is also expected to aid in growth of the market. For instance, according to National Vital Statistics System, the provisional number of births for the U.S. in 2018 was 3,788,235, registering a decrease of 2% from 2017 and the lowest number of births in 32 years.

North America held dominant position in the global human reproductive technologies market in 2019, accounting for 46.1% share in terms of value, followed by Europe and Asia Pacific, respectively.

 Figure 1. Global Human Reproductive Technologies Market Share (%), by Value, by Region, 2019

Global Human Reproductive Technologies Market: Restraints

Limited insurance coverage for ART is expected to hinder growth of the market. ART is a relatively new and yet to be fully proven process in many countries. Such a status causes insurance companies to be apprehensive about covering expenses. For instance, in Canada, there is limited fund for IVF and intracytoplasmic sperm injection and hence infertile couples have to bear the cost of treatment. The average cost for infertility treatment in Canada is quite expensive and ranges from between US$ 10,000 to US$ 20,000.

Moreover, infertility treatments may not prove to be conclusive or effective and thereby need to be repeated sometimes. Such a risk of repetition of procedures negatively affects the decision of the consumers and limits market growth.

Global Human Reproductive Technologies Market: Opportunities 

Increasing rate of literacy is expected to offer lucrative growth opportunities for players in the global human reproductive technologies market. For instance, according to United Nations Children's Fund, globally, the youth literacy rate increased from 83% to 91% during 1985-2018.

Moreover, R&D in male birth control pill is also expected to aid in growth of the market. For instance, in March 2018, researchers from the University of Washington presented positive results from a small clinical trial of 100 men for a male birth control pill that inhibits testosterone production.

The global human reproductive technologies market was valued at US$ 28,426.7 Mn in 2019 and is forecast to reach a value of US$ 34,228.3 Mn by 2027 at a CAGR of 2.4% between 2020 and 2027.

Figure 2. Global Human Reproductive Technologies Market Value (US$ Bn), and Y-o-Y Growth (%), 2019-2027

Market Trends/Key Takeaways

Increasing population is expected to propel demand for emergency human reproductive technologies. For instance, according to projections by Population Reference Bureau (PRB) included in the 2018 World Population Data Sheet, the world population is expected to reach 9.9 billion by 2050, up 2.3 billion or 29% from an estimated 7.6 billion people in 2018.

However, low adoption of emergency human reproductive technologies in emerging economies is expected to act as a drag for the demand. For instance, according to PRB’s 2019 Family Planning Data Sheet, fewer than 15% of married women of reproductive age use a modern human reproductive technologies in Democratic Republic of the Congo. 

 Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/3921

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/3921

 Global Human Reproductive Technologies Market: Competitive Landscape

Major players operating in the global human reproductive technologies include, Abbott Laboratories, Evofem Biosciences, Inc., Actavis Generics (Teva Pharmaceutical Industries Ltd.), Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Uniprix, Gavis Pharmaceuticals (Lupin Limited), Sandoz International GmbH, Aurobindo Pharma Limited, HRA Pharma, SA, Mankind Pharma, Cryos USA, Merck & Co, Bayer HealthCare AG, Church & Dwight, Co. Inc., Allergan, Pfizer, Inc., Agile Therapeutics Inc., BioSante Pharmaceuticals Inc., Mayer Laboratories, Inc., Pantarhei Bioscience B.V., Cook Medical, Inc., Ferring Pharmaceuticals, Johnson & Johnson, Daré Bioscience, Inc., and Merck Serono.

 Global Human Reproductive Technologies Market: Key Developments

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in May 2020, Evofem Biosciences, Inc. received the U.S. Food and Drug Administration (FDA) approval for Phexxi (lactic acid, citric acid and potassium bitartrate) vaginal gel used to prevent pregnancy in females of reproductive potential for use as an on-demand method of contraception.

Major players in the market are also focused on adopting partnership strategies to expand their product portfolio. For instance, in May 2020, Daré Bioscience, Inc., a developer of women’s health solutions partnered with Health Decisions, Inc., a full-service contract research organization (CRO) specializing in women’s health clinical research and diagnostic development, under which Health Decisions will exclusively provide CRO services within the U.S. to support R&D of Daré’s pipeline of contraception, fertility, and gynecological disorders products.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

 What we provide:

Customized Market Research Services

Industry Analysis Services

Business Consulting Services

Market Intelligence Services

Long term Engagement Model

Country Specific Analysis

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/market-insight/human-reproductive-technologies-market-3921

[sheeranalyticsandinsights]

Assisted Reproductive Technology Market will be growing at a CAGR of 11.70% during the forecast 2020 to 2026

According to a new market research report published by sheer analytics and insights, “The assisted reproductive technology market was valued at USD 17.80 Billion in 2018 and is expected to reach USD 43.14 Billion by 2026 growing at a Compound Annual Growth Rate (CAGR) of 11.70% from 2020 to 2026. Rising work load and job pressure towards mankind are increasing the disposable income of the global populations. However, this has led to the rise in stress and physical distortion. In addition, the number of employed female population is increasing with the advancement of days.

Hence, lack of mental relief and changes in lifestyles and food habits are increasing the rates of infertility. The fertility of both male and female population is reducing with the advancement of technologies and exposure of unhealthy food habits. These are the major factors expected to drive the global assisted reproductive technology market during the forecast period. Rise in the median age of first-time conceiving is another factor proving to be a prime cause of fertility defects which in turn will create new necessities and augment the market of growth over the forecast period of 2018-2026.

The Global Assisted Reproductive Technology Market is expected to provide sustainable growth opportunities during the forecast period from 2020 to 2026. This latest industry research study analyzes the Assisted Reproductive Technology Market by various product segments, applications, regions and countries while assessing regional performances of numerous leading market participants.

Browse the Full report on Global Assisted Reproductive Technology Market report at https://www.sheeranalyticsandinsights.com/market-report-research/global-assisted-reproductive-technology-market-report-21

The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others. Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies.

Global Assisted Reproductive Technology Market report summarizes the positive growth rate in upcoming years, and market size with competitive analysis. Our experts have analyzed the historical data to compare with the current market scenario to calculate the market growth in the coming years. The study provides an exhaustive report that includes an executive summary, scope, and forecast of the market.

Key Questions Answered by Assisted Reproductive Technology Market Report

Product popularity and adoption based on various country-level dynamics

Regional presence and product development for leading market participants

Market forecasts and trend analysis based on ongoing investments and economic growth in key countries

Competitive landscape based on revenue, product offerings, years of presence, number of employees and market concentration, among others

number of employees and market concentration, among others

Download free PDF Sample Request: https://www.sheeranalyticsandinsights.com/request-sample/global-assisted-reproductive-technology-market-report-21

List of Companies Covered:

Bloom IVF Centre,

CooperSurgical Inc.,

Cosmos Biomedical,

Cryolab Ltd.,

European Sperm Bank,

Ferring B.V.,

Merck Group,

Irvine Scientific.,

Microm UK Ltd. and

Ovascience.

Global Assisted Reproductive Technology Market Has Been Segmented Into:

By Type

IVF

ICSI

GIFT

IUI

Others

By End-User

Fertility Clinics

Hospitals

By Geography Type    

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Our Blog: https://prnewswireonline.com/

[karishmamulani]

Sperm Banks Market Insights, Overview, Analysis and Forecast 2028

The global sperm bank market expected to reach USD 6.07 billion by 2028 according to a new study by Polaris Market Research. The report “Sperm Bank Market Share, Size, Trends, Industry Analysis Report, By Service Type (Sperm Storage, Semen Analysis, Genetic Consultation); By Donor Type (Known Donor, Anonymous Donor); By End-Use (Donor Insemination, In-vitro Fertilization), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global sperm bank industry is driven by few notable factors such as rising cases of infertility among both men and women, innovations in assistive reproductive techniques, and an increasing number of infertility care centers across the globe. Moreover, the growing awareness among consumers in the middle-income countries also boosting the industry growth.

The global sperm bank industry is fragmented based on service type, donor, end-use, and region. In terms of service type, the market is segmented sperm storage, semen analysis, and genetic consultation. Based on the donor type, the market is classified as known and anonymous donors. The end-use segment is further divided into donor insemination and in-vitro fertilization.

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/sperm-bank-market/request-for-sample

Segment Highlights

The semen analysis segment accounted for the largest revenue share in 2020 owing to its use in examination of sperm count and associated complications. The market segment accounted for over 45% of the global market in 2020.

Known donor market segment accounted for over 50% of the revenue share in 2020 and is expected to dominate across the forecast period owing to the several right to know your biological parent mandates in developed economies.

Based on end-use, the in-vitro fertilization market segment is projected to constitute over 95% of the market share by 2028. This can be attributed to the rising cases of miscarriages and high success rate of in-vitro fertilization.

North America sperm bank industry is expected to dominate the global market. Rising awareness among individuals about the ill-effects of infertility and the presence of robust infrastructure for sperm banking services are the factors responsible for market growth.

Fairfax Cryobank Inc., Xytex Corporation, Andocryos, Cryo-Save AG, New England Cryogenic Center, Seattle Sperm Bank, and Indian Spermtech are few of the major players operating in the market space.

List of Key Players

Fairfax Cryobank Inc.

Xytex Corporation

Andocryos

Cryo-Save AG

Indian Spermtech

New England Cryogenic Center

Seattle Sperm Bank

London Sperm Bank

Others

Have Any Query Or Specific Requirement? Feel Free To Ask Our Industry Experts At : https://www.polarismarketresearch.com/industry-analysis/sperm-bank-market/speak-to-analyst

Polaris Market Research has segmented the Sperm Bank Market report on the basis of service type, donor type, end-use, and region

Sperm Bank, Service Type Outlook (Revenue – USD Million, 2016 – 2028)

Sperm storage

Semen analysis

Genetic consultation

Sperm Bank, Donor Outlook (Revenue – USD Million, 2016 – 2028)

Known donor

Anonymous donor

Sperm Bank, End-Use Outlook (Revenue – USD Million, 2016 – 2028)

Donor insemination

In vitro fertilization

Sperm Bank, Regional Outlook (Revenue – USD Million, 2016 – 2028)

North America

Europe

Asia Pacific

Central & South America

Middle East & Africa

U.S.

Canada

France

Germany

UK

Italy

Spain

Netherlands

Austria

China

India

Japan

Malaysia

South Korea

Indonesia

Mexico

Brazil

Argentina

UAE

Saudi Arabia

Israel

South Africa

Read More : https://www.medgadget.com/2021/01/sperm-bank-market-size-is-projected-to-reach-6-07-billion-by-2028-cagr-3-5-polaris-market-research.html

[kunalcmi]

INFERTILITY DRUGS AND DEVICES MARKET ANALYSIS (2020-2027)

Infertility means not being able to become pregnant after a year of trying. Drugs, Assisted Reproductive Technology (ART), surgery, artificial insemination,   and in vitro fertilization are common treatments.  

Statistics:

The global infertility drugs and devices market is estimated to account for US$ 9,702.4 Mn in terms of value by the end of 2027.

 Global Infertility Drugs and Devices Market: Drivers

Increasing prevalence of infertility is expected to propel growth of the global infertility drugs and devices market over the forecast period. For instance, according to the National Survey of Family Growth data published in September 2018, 15.5% of all women who intend to become pregnant are infertile and 6.7% of married women aged 15 to 44 years are infertile, in the U.S.

Moreover, increasing homosexual population is also expected to aid in growth of the market. For instance, in March 2019, Williams Institute at the UCLA School of Law reported that around 4.5% of the U.S. adults were identified as lesbian, gay, bisexual or transgender.

 Statistics:

North America held dominant position in the global infertility drugs and devices market in 2019, accounting for 35.7% share in terms of value, followed by Europe and Asia Pacific, respectively.

 Figure 1: Global Infertility Drugs and Devices Market Share (%) Value, By Region, 2019

Global Infertility Drugs and Devices Market: Restraints

Limited insurance coverage for ART is expected to hinder growth of the market. ART is a relatively new and yet to be fully proven process in many countries. Such a status causes insurance companies to be apprehensive about covering expenses. For instance, in Canada, there is limited fund for IVF and intracytoplasmic sperm injection and hence infertile couples have to bear the cost of treatment. The average cost for infertility treatment in Canada is quite expensive and ranges from between US$ 10,000 to US$ 20,000.

Moreover, high prevalence of sexually transmitted diseases with erectile dysfunction drug users is also expected to hinder growth of the market. PDE 5 inhibitors, though the first line treatment in erectile dysfunction, are associated with a major concern of the transfer of sexually transmitted diseases (STDs). Various studies carried out to analyze differences in the prevalence of STDs among men who use erectile dysfunction drugs versus those who do not have reported that users of erectile dysfunction drugs had higher rates of STDs, particularly HIV and Chlamydia infection, than the non-users.

 Global Infertility Drugs and Devices Market: Opportunities

Increasing rate of literacy is expected to offer lucrative growth opportunities for players in the global infertility drugs and devices market. For instance, according to United Nations Children's Fund, globally, the youth literacy rate increased from 83% to 91% during 1985-2018.

Moreover, expiry of drug patents is expected to offer lucrative opportunities for development of generics. For instance, Eli Lilly and Company’s drug, Cialis used for treatment of erectile dysfunction, lost patent protection in September 2018. In October 2018, Teva Pharmaceutical launched a generic version of Cialis in the U.S.

Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/4122

 Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/4122

 Statistics:

The global infertility drugs and devices market was valued at US$ 6,096.7 Mn in 2019 and is forecast to reach a value of US$ 9,702.4 Mn by 2027 at a CAGR of 5.8% between 2020 and 2027.

 Figure 2: Global Infertility Drugs and Devices Market Value (US$ Mn), 2016 – 2027

Market Trends/Key Takeaways

Initiatives to increase awareness regarding human reproductive technologies is expected to propel growth of the market. For instance, in February 2020, Cryos USA, a sperm and egg bank based in the U.S., held a scientific symposium on Assisted Reproductive Technology (ART).

 The market is witnessing increasing launch of generics. For instance, in March 2019, Dr. Reddy's Laboratories launched a generic version of Cialis (Tadalafil) tablets for treatment of erectile dysfunction, in the U.S. market.

 Global Infertility Drugs and Devices Market: Competitive Landscape

Major players operating in the global infertility drugs and devices market include, Apricus Biosciences, Inc., Bayer AG, Cristalia Produtos Quimicos Farmaceuticos Ltda., Dong-A Pharmaceutical Co. Ltd., Eli Lilly and Company, Meda Pharmaceuticals, Inc., Pfizer, Inc., S.K. Chemicals Co. Ltd., Vivus, Inc. Mylan Pharmaceuticals Inc., Ferring Pharmaceuticals, Cipla Ltd, Aspargo Laboratories, Inc., Aurobindo Pharma Ltd., Lupin Limited, Novartis International AG, Daré Bioscience, Inc., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals, and Dr. Reddys Laboratories Ltd.

 Global Infertility Drugs and Devices Market: Key Developments

 Major players in the market are also focused on adopting partnership strategies to expand their product portfolio. For instance, in May 2020, Daré Bioscience, Inc., a developer of women’s health solutions partnered with Health Decisions, Inc., a full-service contract research organization (CRO) specializing in women’s health clinical research and diagnostic development, under which Health Decisions will exclusively provide CRO services within the U.S. to support R&D of Daré’s pipeline of contraception, fertility, and gynecological disorders products.

Major players in the market are also focused on launching generic drugs to expand their product portfolio. For instance, in September 2019, Lupin Limited launched Sildenafil tablets, USP of 25 mg, 50 mg, and 100 mg, a generic version of Pfizer Inc.’s Viagra tablets.

 About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

Customized Market Research Services

Industry Analysis Services

Business Consulting Services

Market Intelligence Services

Long term Engagement Model

Country Specific Analysis 

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

 Source: https://www.coherentmarketinsights.com/market-insight/infertility-drugs-and-devices-market-4122

[market-insider]

Assisted Reproductive Technology Market Worth $45,455.9 Million By 2025

The global assisted reproductive technology (ART) market is expected to reach USD 45 billion by 2025, according to a new report by Grand View Research, Inc. Childbearing postponement is one of the high impact rendering drivers of the infertility treatment market. The reproductive behavior and pattern of some of the nations such as few European nations have shifted from early to late childbearing pattern.

Increasing marital age, rising tobacco and alcohol consumption, increasing obesity rate are some of the other factors contributing to the market growth. Furthermore, increasing incidence rate of conditions such as poly-cystic ovarian syndrome (PCOS), tubal factors and endometriosis are other drivers of the market.

According to the Society for Assisted Reproductive Technology, 2012 was the year with highest percentage of babies born through IVF treatment. The treatment has become more successful and has gained more acceptance, which is further expected to increase the market size in the coming years.

For More Details Please Visit @: https://www.grandviewresearch.com/industry-analysis/assisted-reproductive-technology-market

Further Key Findings from the Report Suggest:

·         Fresh non-donor was the largest ART market procedure segment in 2014. The fact that fresh eggs and sperms increase the number of successful pregnancies is expected to drive segment growth over the forecast period.

·         According to a recent study published in the New England Journal of Medicine.by the researchers from Vietnam and China, frozen embryos are not more effective in comparison to the fresh embryos for all women, specifically those suffering from PCOS.

·         Frozen non-donor is identified as the most lucrative procedure segment of the assisted reproductive technology industry. A new study claims that the fertility treatment with frozen embryos may have more probability of success than those performed with fresh embryos.

·         IVF with ICSI dominated the technology type market segment owing to increase in the chances of successful fertilization, and exceptional technique for treating male infertility. As per the study published in fertility journal Human Reproduction Update 2017, North America, Europe, New Zealand and Australia, men’s sperm counts declined by 50-60% over the period between 1973 and 2011. Changing lifestyle and environmental factors are some of the factors responsible for the decline of sperm counts.

·         Europe dominated the market and is anticipated to maintain its dominance during the forecast period The Asia Pacific region is likely to witness significant growth over the next decade due to improving healthcare infrastructure, increasing awareness and adoption of IVF procedures.

·         Technological advancements is expected to drive the market in the coming years. In 2016, INVO Bioscience, Inc. announced the FDA approval of first intravaginal culture system, INVOcell, wherein women’s vagina is used as a natural incubator and the clinical trials have produced pregnancy similar to traditional IVF treatments

·         Some of the key players are California Cryobank, Bloom IVF Centre, Parallabs, OvaScience, Anecova, Origio, Microm Ltd., Merck KGaA, Ferring Pharmaceuticals, Boston Science Corporation and Hamilton Throne Ltd.

Grand View Research has segmented the global assisted reproductive technology market based on procedure, type, end use and region:

Procedure Outlook (Revenue, USD Million, 2014 - 2025)

·         Fresh Donor

·         Fresh Non-Donor

·         Frozen Donor

·         Frozen Non-donor

·         Embryo/Egg Banking

Type Outlook(Revenue, USD Million, 2014 - 2025)

·         In-Vitro Fertilization (IVF)

o    IVF with Intracytoplasmic Sperm Injection (ICSI)

o    IVF without Intracytoplasmic Sperm Injection (ICSI)

·         Others

End Use Outlook (Revenue, USD Million, 2014 - 2025)

·         Hospitals

·         Fertility Clinics

Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    France

o    Germany

·         Asia Pacific

o    China

o    Japan

o    India

·         Latin America

o    Brazil

o    Mexico

·         Middle East & Africa

o    South Africa